Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study.

Shinichiro ShinzakiKatsuyoshi MatsuokaHiroki TanakaFuminao TakeshimaShingo KatoTakehiro TorisuYuki OhtaKenji WatanabeShiro NakamuraNaoki YoshimuraTaku KobayashiAkiko ShiotaniFumihito HiraiSakiko HiraokaMamoru WatanabeMinoru MatsuuraShohei NishimotoShinta MizunoHideki IijimaTetsuo TakeharaTetsuji NakaTakanori KanaiTakayuki Matsumoto

Published in: Journal of gastroenterology (2021)

Serum LRG is a useful biomarker of endoscopic activity both in CD and UC during the adalimumab treatment.

Keyphrases

disease activity
rheumatoid arthritis
juvenile idiopathic arthritis
systemic lupus erythematosus
rheumatoid arthritis patients
ankylosing spondylitis
ultrasound guided
hidradenitis suppurativa
combination therapy
replacement therapy
nk cells